Haroun Gajraj: Upto 30% of Patients Develop Brown Marks After Microsclerotherapy
Haroun Gajraj, Phlebologist and Board Member of the British Association of Sclerotherapists, shared a post on LinkedIn:
“Upto 30% of Patients Develop Brown Marks After Microsclerotherapy
That’s not a rare complication.
That’s one in three.
In fact if it occurs in 30% is it really a complication?
Is it a side effect?
Is it an expectation?
For a procedure patients choose to improve their appearance, post-sclerotherapy hyperpigmentation can be more distressing than the original spider veins – and more damaging to your patient relationship.
But can it be mitigated by the consultation process?
The question isn’t whether it happens in your practice.
It’s whether you know WHY it happens – and What to do about it.”
Other posts featuring Haroun Gajraj on Hemostasis Today.
-
May 20, 2026, 07:50Karen Schreiber: The BBQ Trial and the Challenge of Conducting Pregnancy RCTs
-
May 20, 2026, 07:49Dilini Christina Ranasinghe: Paediatric TPE Is Not Simply Adult TPE in a Smaller Patient
-
May 20, 2026, 07:42Manuel Carbonell: Combining Sclerotherapy and Laser Technology in Modern Vein Treatment
-
May 20, 2026, 07:15Is Postpartum DOAC Use A Real-World Alternative to LMWH and VKA? – JTH
-
May 20, 2026, 07:07Arman Qamar: Can Ischemic Stroke Polygenic Risk Scores Predict Recurrent Events After Coronary Revascularization?
-
May 20, 2026, 06:59Erin VanDyke: PE Is an Opportunity to Reflect on How We Could Have Better Handled a DVT
-
May 20, 2026, 06:53Fayad Al-Haimus: The TOWAR Trial On Comaprison of Whole Blood vs Component Therapy in Trauma
-
May 20, 2026, 06:09Jesse Solar: Supporting Safer Pregnancies Through Clot Awareness
-
May 20, 2026, 05:59Enhancing Patient Care Through Hemophilia Education – Kenya Haemophilia Association